BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37992565)

  • 1. Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology.
    Zhao K; Zhang H; Cui J; Zhang Y; Zhou T; Long B
    Stem Cell Res; 2023 Dec; 73():103255. PubMed ID: 37992565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a RGS18 gene knockout cell line from a human embryonic stem cell line by CRISPR/Cas9.
    Feng Y; Li X; Zhang L; Sun Y; He Y; Wen R; Hu Y; Wang X; Liu J; Long B
    Stem Cell Res; 2020 Dec; 49():102072. PubMed ID: 33157388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of FOS gene knockout lines from a human embryonic stem cell line using CRISPR/Cas9.
    Li C; Wang Q; Peng Z; Lin Y; Liu H; Yang X; Li S; Liu X; Chen J
    Stem Cell Res; 2019 Aug; 39():101479. PubMed ID: 31229900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of RYBP FLAG-HA knock-in human embryonic stem cell line through CRISPR/Cas9-mediated homologous recombination.
    Zhang J; Zhou T; Shan Y; Pan G
    Stem Cell Res; 2022 Jul; 62():102803. PubMed ID: 35537243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system.
    Wu X; Wang X
    Stem Cell Res; 2023 Jun; 69():103082. PubMed ID: 36963213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology.
    Zhang D; Zhou M; Zhang Y; Shan Y; Pan G
    Stem Cell Res; 2022 Jul; 62():102809. PubMed ID: 35567848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing.
    Wu F; Gao G; Pan T; Yang Z; Xu G; Abbas N; Liu Y; Chen Y; Tan S; You K; Ke X; Zhuang Y; Lin X; Yang F; Li YX
    Stem Cell Res; 2018 Mar; 27():5-9. PubMed ID: 29278761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a GFI1-flag knock-in human embryonic stem cell line using CRISPR-Cas9 technology.
    Kang B; Cong Z; Duan J; Liu K; Wang Y
    Stem Cell Res; 2022 Apr; 60():102724. PubMed ID: 35248880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.
    Sun W; Li X; Dong J; Zhou Y
    Stem Cell Res; 2024 Feb; 74():103284. PubMed ID: 38118206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system.
    Si L; Yang R; Liu J; Dong Y; Zhang H; Xu X
    Stem Cell Res; 2019 Dec; 41():101644. PubMed ID: 31743839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing.
    Ma S; Xu Q; Bai R; Dong T; Peng Z; Liu X
    Stem Cell Res; 2021 Aug; 55():102470. PubMed ID: 34352617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
    Wang W; Bai R; Song X
    Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9.
    Bai J; Zhang J; Fu W; Li S; Tian X; Li X; Zhao X; Dong J
    Stem Cell Res; 2023 Mar; 67():103040. PubMed ID: 36796252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a DKK1 homozygous knockout human embryonic stem cell line WAe001-A-21 using CRISPR/Cas9.
    Yang Z; Yuan F; Wang N; Liu Y; Zhang J; Wei R; Wu F; Wu Y; You K; Chen Y; Yang F; Li YX
    Stem Cell Res; 2021 Mar; 51():102161. PubMed ID: 33461039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9.
    Wang X; Sun J; Fu C; Liu C
    Stem Cell Res; 2023 Jun; 69():103077. PubMed ID: 36965407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9.
    Yuan F; Guo D; Gao G; Liu Y; Xu Y; Wu Y; Yang F; Ke X; Lai K; Hong L; Li YX
    Stem Cell Res; 2017 Oct; 24():89-93. PubMed ID: 29034901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
    Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
    Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a homozygous ALX1 knockout human embryonic stem cell line (WAe001-A-060) by a CRISPR/Cas9 system.
    Xiao X; Chen Y; Peng L; Zhang T
    Stem Cell Res; 2021 May; 53():102309. PubMed ID: 33799274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout human embryonic stem cell line.
    Zhang C; Wei Y; Zhang Y; Zhang J; Xing Q; Zhou M; Shan Y
    Stem Cell Res; 2021 Apr; 52():102234. PubMed ID: 33607472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.